The document discusses cell cycle, apoptosis, and cancer. It defines cell cycle as the process of growth and division of cells. Apoptosis is programmed cell death activated when DNA damage exceeds repair capacity. Cancer occurs due to deregulation of cell cycle and apoptosis mechanisms, resulting in uncontrolled cell growth and proliferation. Various genetic, chemical, physical, and viral factors can cause cancer.
The document discusses cell cycle, apoptosis, and cancer. It defines cell cycle as the process of growth and division of cells. Apoptosis is programmed cell death activated when DNA damage exceeds repair capacity. Cancer occurs due to deregulation of cell cycle and apoptosis mechanisms, resulting in uncontrolled cell growth and proliferation. Various genetic, chemical, physical, and viral factors can cause cancer.
The document discusses cell cycle, apoptosis, and cancer. It defines cell cycle as the process of growth and division of cells. Apoptosis is programmed cell death activated when DNA damage exceeds repair capacity. Cancer occurs due to deregulation of cell cycle and apoptosis mechanisms, resulting in uncontrolled cell growth and proliferation. Various genetic, chemical, physical, and viral factors can cause cancer.
The document discusses cell cycle, apoptosis, and cancer. It defines cell cycle as the process of growth and division of cells. Apoptosis is programmed cell death activated when DNA damage exceeds repair capacity. Cancer occurs due to deregulation of cell cycle and apoptosis mechanisms, resulting in uncontrolled cell growth and proliferation. Various genetic, chemical, physical, and viral factors can cause cancer.
College of Medicine U of J CellCycle Apoptosis Cancer. Cellcycle refers to the order process by which each living cell undergoes growth and cell division resulting in the formation of two daughter cells.
Each cell contains exactly the same genetic
information as the parent.
Eukaryotic cell divide on average once
every 18 to 24 hours. G1 (Gap1) 4 hours: RNA and protein synthesis occur in response to exogenous growth factors (mitogens) to create the proteins that are needed to replicate DNA in the next phase. S (synthesis) 8 hours: DNA is replicated and RNA and proteins are synthesized. G2 (Gap2) 12 hours: RNA and protein synthesis continues and integrity of the DNA is checked as the cell prepares to spilt/divide into two. 4. M (mitosis): Nuclear and cytoplasmic division occurs to create two identical daughter cells. This phase is further divided into prophase, metaphase, anaphase, telophase and cytokinesis. G0 is a phase where cells have exited the cell cycle and are not growing or dividing. However they synthesize just enough RNA and protein for general housekeeping or for specialized functions. A defect in mismatch repair in humans result in hereditary nonpolyposis colon cancer (HNPCC).
One of the most common inherited cancers.
When eukaryotic cells accumulate DNA that is beyond repair capacity , they activate a process of programmed cell death called apoptosis (Greek word for “falling off”).
Apoptosis is performed by a cascade of
intracellular proteases called Caspases. Caspases (cysteine-aspartic proteases, cysteine aspartases or cysteine-dependent aspartate-directed proteases) are a family of protease enzymes playing essential roles in programmed cell death (including apoptosis, pyroptosis and necroptosis) and inflammation. Cancer is defined as the uncontrolled growth and proliferation of somatic cells. It occurs due to failure of the of the normal regulatory mechanisms that control the cell cycle and apoptosis. Cancer is a genetic disease in the sense that it involves an abnormal increase or decrease in the expression of a set of critical genes. Such abnormal gene expression is the result of genetic damage caused by chemical or physical agents, hormones, and in some cases viruses. Cancer cells are characterized by: diminished or uncontrolled growth. invasion of local tissues. spread or metastasis (the development of secondary malignant growths at a distance from a primary site of cancer) to other parts of the body. Radiation energy. Ultraviolet, X-rays and Gamma rays are carcinogenic and mutagenic. Many chemicals. Polycyclic aromatic hydrocarbons e.g., Benzo (a) pyrene, dimethybenzanthracene. Aromatic amines-2-acetylaminofluorene. Nitrosamines: Dimethylnitrosamine, diethylnitrosamine. Various drugs- Alkylating agents cyclophosphamide. Naturally occurring compounds- dactomycin, aflatoxin B. Inorganic compounds-Arsenic, asbestos, beryllium, cadmium, chromium Some chemicals undergo changes from procarcinogenic to proximate carcinogen to finally ultimate carcinogen. DNA viruses: Papovaviruses. Adenoviruses Herpesviruses Hepadnavirus. RNA viruses Retrovirus type c and type b. These are genes that are capable of causing cancer. Eg: Abl, fos, fes, jun, myc etc. Proto-Oncogenes are activated to Oncogenes by various mechanisms: Promoter insertion Enhencer insertion. Chromosomal insertion. Gene amplification. Point mutation. RB1 is a tumor suppressor gene involved in the genesis of retinoblastoma. P53 is a tumor suppressor gene that the guardian of the genome. ABC-Familial adenomatous polyposis. BRCA1-Familial breast and ovarian cancer. NF1-Neurofibromatosis type1 NF2-Neurofibromatosis type2 RB-Retinoblastoma. WT1-Wilms tumor (kidney). Many cancers are associated with abnormal production of enzymes, proteins and hormones which can be measured in the serum.
These molecules are known as tumor
markers. Carcinoembryonic antigen (CEA)-colon, lung, breast, pancreas. Alpha-fetoprotein (AFP)-Liver, germ cell. Human chorionic gonadotropin (hCG)- Trophoblast, germ cell. Calcitonin (CT)-Thyroid (medullary carcinoma) Prostatic acid phosphatase (PAP)-Prostate. Detection: screening in asymptomatic persons. Diagnosis: Differentiating malignant from benign conditions. Monitoring: Predicting effect of therapy and detecting recurrent cancer. Classification: Choosing therapy and predicting tumor behavior. Staging: Defining extent of disease. Localization: Nuclear scanning of injected radioactive antibodies. Therapy: Cytotoxic agents directed to marker- containing cells.